High-dose melphalan produces favorable response in a patient with multiple myeloma and coexisting essential thrombocythemia with JAK2 mutation

Bone Marrow Transplant. 2014 Jan;49(1):148-9. doi: 10.1038/bmt.2013.117. Epub 2013 Aug 12.

¹ 1] Department of Blood and Marrow Transplantation, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA [2] Department of Oncological Sciences, H. Lee Moffitt Cancer Center/University of South Florida College of Medicine, Tampa, FL, USA.
² Division of Hematology-Oncology, American University of Beirut Medical Center, Beirut, Lebanon.
³ Department of Hematopathology and Laboratory Medicine, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA.
⁴ Department of Malignant Hematology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA.

No abstract available

Publication types